Atormac
Neurology India
Open access journal indexed with Index Medicus
  Users online: 1038  
 Home | Login 
  About Current Issue Archive Ahead of print Search Instructions Online Submission Subscribe Etcetera Contact  
Read this article

 


    Article Cited by others



A double blind controlled study of propranolol and cyproheptadine in migraine prophylaxis.

Rao B S, Das D G, Taraknath V R, Sarma Y

Year : 2000| Volume: 48| Issue : 3 | Page no: 223-6

   This article has been cited by
 
1 Emerging drugs in migraine treatment
Waeber, C.
Expert Opinion on Emerging Drugs. 203; 8(2): 437-456
[Pubmed]  [Google Scholar]
2 Preventive treatment in migraine and the new US guidelines
Estemalik, E. and Tepper, S.
Neuropsychiatric Disease and Treatment. 2013; 9: 709-720
[Pubmed]  [Google Scholar]
3 Pharmacologic treatment of pediatric headaches: A meta-analysis
El-Chammas, K. and Keyes, J. and Thompson, N. and Vijayakumar, J. and Becher, D. and Jackson, J.L.
JAMA Pediatrics. 2013; 167(3): 250-258
[Pubmed]  [Google Scholar]
4 Treatment of headache in the elderly
Hershey, L.A. and Bednarczyk, E.M.
Current Treatment Options in Neurology. 2013; 15(1): 56-62
[Pubmed]  [Google Scholar]
5 Migraine and childhood periodic syndromes in children and adolescents
Gelfand, A.A.
Current Opinion in Neurology. 2013; 26(3): 262-268
[Pubmed]  [Google Scholar]
6 Potential benefits of cyproheptadine in HIV-positive patients under treatment with antiretroviral drugs including efavirenz
Dabaghzadeh, F. and Khalili, H. and Ghaeli, P. and Dashti-Khavidaki, S.
Expert Opinion on Pharmacotherapy. 2012; 13(18): 2613-2624
[Pubmed]  [Google Scholar]
7 Efficacy and safety of cinnarizine in the prophylaxis of migraine headaches in children: An open, randomized comparative trial with propranolol
Togha, M. and Malamiri, R.A. and Rashidi-Ranjbar, N. and Asa, S. and Mahvelati, F. and Ashrafi, M.R.
Acta Neurologica Belgica. 2012; 112(1): 51-55
[Pubmed]  [Google Scholar]
8 Evidence-based guideline update: NSAIDs and other complementary treatments for episodic migraine prevention in adults Report of the quality standards subcommittee of the american academy of neurology and the American headache society
Holland, S. and Silberstein, S.D. and Freitag, F. and Dodick, D.W. and Argoff, C. and Ashman, E.
Neurology. 2012; 78(17): 1346-1353
[Pubmed]  [Google Scholar]
9 Evidence-based guideline update: Pharmacologic treatment for episodic migraine prevention in adults report of the quality standards subcommittee of the American academy of neurology and the american headache society
Silberstein, S.D. and Holland, S. and Freitag, F. and Dodick, D.W. and Argoff, C. and Ashman, E.
Neurology. 2012; 78(17): 1337-1345
[Pubmed]  [Google Scholar]
10 Effect of preventive (β blocker) treatment, behavioural migraine management, or their combination on outcomes of optimised acute treatment in frequent migraine: Randomised controlled trial
Holroyd, K.A. and Cottrell, C.K. and OĉDonnell, F.J. and Cordingley, G.E. and Drew, J.B. and Carlson, B.W. and Himawan, L.
BMJ (Online). 2010; 341(7776): 769
[Pubmed]  [Google Scholar]
11 Migraine: Preventive treatment
Silberstein, S.D.
Handbook of Clinical Neurology. 2010; 97(C): 337-354
[Pubmed]  [Google Scholar]
12 Migraine and the hypothalamus
Alstadhaug, K.
Cephalalgia. 2009; 29(8): 809-817
[Pubmed]  [Google Scholar]
13 Pediatric Migraine
Lewis, D.W.
Neurologic Clinics. 2009; 27(2): 481-501
[Pubmed]  [Google Scholar]
14 Optimizing prophylactic treatment of migraine: Subtypes and patient matching
Dib, M.
Therapeutics and Clinical Risk Management. 2008; 4(5): 1061-1078
[Pubmed]  [Google Scholar]
15 Chemical biology - Understanding biology and advancing therapy
Schimmer, A.D.
Clinical and Investigative Medicine. 2008; 31(5): E282-E289
[Pubmed]  [Google Scholar]
16 Cyproheptadine displays preclinical activity in myeloma and leukemia
Mao, X., Liang, S.-B., Hurren, R., Gronda, M., Chow, S., Wei Xu, G., Wang, X., (...), Schimmer, A.D.
Blood. 2008; 112(3): 760-769
[Pubmed]  [Google Scholar]
17 Newer aspects of migraine preventive therapies
Freitag, F.G.
Drug Development Research. 2007; 68(6): 315-320
[Pubmed]  [Google Scholar]
18 Pediatric migraine: Pharmacologic agents for prophylaxis
Eiland, L.S., Jenkins, L.S., Durham, S.H.
Annals of Pharmacotherapy. 2007; 41(7-8): 1181-1190
[Pubmed]  [Google Scholar]
19 Prophylactic treatment of migraine | [Tratamiento farmacológico preventivo de la migraña]
Benito-León, J., Morales-González, J.M., Collar, J.M.
Medicina Clinica. 2006; 126(12): 467-472
[Pubmed]  [Google Scholar]
20 Prophylactic activity of cyproheptadine and Bellergal on migraine headache
Mehvari, J., Rafieian-Kopaei, M.
Iranian Journal of Medical Sciences. 2005; 30(2): 84-87
[Pubmed]  [Google Scholar]
21 Aquagenic urticaria with extracutaneous manifestations
Baptist, A.P., Baldwin, J.L.
Allergy and Asthma Proceedings. 2005; 26(3): 217-220
[Pubmed]  [Google Scholar]
22 Preventive treatment of migraine: Effect on weight
Young, W.B., Rozen, T.D.
Cephalalgia. 2005; 25(1): 1-11
[Pubmed]  [Google Scholar]
23 Prophylactic treatment of pediatric migraine
Lewis DW, Diamond S, Scott D, et al.
HEADACHE. 2004; 44 (3): 230-237
[Pubmed]  [Google Scholar]
24 Migraine
Clinical Neurology. 2002; 42(4): 333-347
[Pubmed]  [Google Scholar]
25 Treatment of paediatric headache
Lewis, D.W., Scott, D., Rendin, V.
Expert Opinion on Pharmacotherapy. 2002; 3(10): 1433-1442
[Pubmed]  [Google Scholar]
26 Prophylactic treatment of migraine
Journal of Headache and Pain. 2001; 2(3): 147-161
[Pubmed]  [Google Scholar]

 

Online since 20th March '04
Published by Wolters Kluwer - Medknow